US Stock MarketDetailed Quotes

Medpace (MEDP)

Watchlist
  • 417.180
  • +6.640+1.62%
Trading Apr 27 14:35 ET
11.91BMarket Cap26.25P/E (TTM)

Medpace (MEDP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
26.50%706.6M
19.97%2.53B
32.03%708.45M
23.74%659.9M
14.24%603.31M
9.30%558.57M
11.84%2.11B
7.66%536.59M
8.29%533.32M
14.59%528.1M
Operating revenue
26.50%706.6M
19.97%2.53B
32.03%708.45M
23.74%659.9M
14.24%603.31M
9.30%558.57M
11.84%2.11B
7.66%536.59M
8.29%533.32M
14.59%528.1M
Cost of revenue
34.21%510.28M
21.81%1.77B
40.43%503.13M
27.08%462.96M
13.10%423.3M
6.83%380.22M
6.71%1.45B
-0.92%358.27M
1.39%364.31M
11.21%374.27M
Gross profit
10.08%196.33M
15.89%760.62M
15.14%205.32M
16.53%196.94M
17.01%180.01M
14.96%178.35M
25.13%656.31M
30.34%178.32M
26.89%169.01M
23.75%153.84M
Operating expense
-15.43%54.82M
7.76%225.68M
-1.68%52.05M
-2.83%55.13M
10.25%53.68M
26.93%64.83M
11.59%209.44M
6.98%52.94M
17.50%56.74M
6.02%48.69M
Selling and administrative expenses
-17.24%47.92M
9.64%197.56M
-1.14%44.92M
-2.31%48.08M
12.57%46.66M
31.34%57.9M
11.67%180.18M
6.87%45.43M
18.86%49.22M
5.20%41.45M
Depreciation amortization depletion
-0.35%6.91M
-3.85%28.12M
-5.00%7.13M
-6.24%7.05M
-3.05%7.01M
-0.89%6.93M
11.10%29.25M
7.66%7.51M
9.31%7.52M
10.97%7.24M
-Depreciation and amortization
-0.35%6.91M
-3.85%28.12M
-5.00%7.13M
-6.24%7.05M
-3.05%7.01M
-0.89%6.93M
11.10%29.25M
7.66%7.51M
9.31%7.52M
10.97%7.24M
Operating profit
24.65%141.5M
19.71%534.94M
22.25%153.27M
26.31%141.81M
20.15%126.34M
9.08%113.52M
32.67%446.87M
43.58%125.38M
32.23%112.27M
34.13%105.15M
Net non-operating interest income expense
-20.83%5.12M
-48.87%12.78M
-52.78%3.72M
-79.85%1.52M
-80.27%1.08M
56.87%6.46M
5,222.13%25M
327.49%7.88M
7,269.52%7.53M
500.07%5.47M
Total other finance cost
20.83%-5.12M
48.87%-12.78M
52.78%-3.72M
79.85%-1.52M
80.27%-1.08M
-56.87%-6.46M
-5,222.13%-25M
-327.49%-7.88M
-7,269.52%-7.53M
-500.07%-5.47M
Other net income (expense)
153.47%971K
-231.61%-5.34M
-125.44%-158K
52.29%-489K
-2,061.65%-2.88M
-139.54%-1.82M
719.24%4.06M
-59.75%621K
36.02%-1.03M
89.63%-133K
Gain on sale of security
----
-1,458.67%-7.73M
----
----
----
----
74.29%-496K
----
----
----
Other non- operating income (expenses)
153.47%971K
-47.43%2.39M
577.98%7.57M
52.29%-489K
-2,061.65%-2.88M
-139.54%-1.82M
257.30%4.55M
-67.83%1.12M
36.02%-1.03M
89.63%-133K
Income before tax
24.90%147.59M
13.96%542.38M
17.14%156.83M
20.26%142.84M
12.72%124.54M
4.78%118.17M
41.78%475.92M
47.60%133.88M
42.76%118.78M
45.86%110.48M
Income tax
563.52%23.72M
27.56%91.25M
28.68%21.7M
41.84%31.7M
54.89%34.28M
-64.92%3.58M
35.30%71.54M
35.90%16.86M
76.67%22.35M
50.80%22.13M
Net income
8.09%123.87M
11.56%451.12M
15.48%135.13M
15.25%111.14M
2.16%90.26M
11.70%114.6M
42.99%404.39M
49.45%117.02M
36.68%96.43M
44.68%88.35M
Net income continuous Operations
8.09%123.87M
11.56%451.12M
15.48%135.13M
15.25%111.14M
2.16%90.26M
11.70%114.6M
42.99%404.39M
49.45%117.02M
36.68%96.43M
44.68%88.35M
Minority interest income
Net income attributable to the parent company
8.09%123.87M
11.56%451.12M
15.48%135.13M
15.25%111.14M
2.16%90.26M
11.70%114.6M
42.99%404.39M
49.45%117.02M
36.68%96.43M
44.68%88.35M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
-76.96%44K
-94.34%3K
0
0
Net income attributable to common stockholders
8.09%123.87M
11.57%451.12M
15.48%135.13M
15.25%111.14M
2.16%90.26M
11.75%114.6M
43.07%404.34M
49.55%117.02M
36.77%96.43M
44.77%88.35M
Basic earnings per share
15.38%4.35
19.75%15.64
26.46%4.78
27.01%3.95
10.88%3.16
13.55%3.77
41.96%13.06
48.24%3.78
35.22%3.11
42.50%2.85
Diluted earnings per share
16.62%4.28
20.98%15.28
27.25%4.67
28.24%3.86
12.73%3.1
14.69%3.67
42.23%12.63
49.19%3.67
35.59%3.01
42.49%2.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 26.50%706.6M19.97%2.53B32.03%708.45M23.74%659.9M14.24%603.31M9.30%558.57M11.84%2.11B7.66%536.59M8.29%533.32M14.59%528.1M
Operating revenue 26.50%706.6M19.97%2.53B32.03%708.45M23.74%659.9M14.24%603.31M9.30%558.57M11.84%2.11B7.66%536.59M8.29%533.32M14.59%528.1M
Cost of revenue 34.21%510.28M21.81%1.77B40.43%503.13M27.08%462.96M13.10%423.3M6.83%380.22M6.71%1.45B-0.92%358.27M1.39%364.31M11.21%374.27M
Gross profit 10.08%196.33M15.89%760.62M15.14%205.32M16.53%196.94M17.01%180.01M14.96%178.35M25.13%656.31M30.34%178.32M26.89%169.01M23.75%153.84M
Operating expense -15.43%54.82M7.76%225.68M-1.68%52.05M-2.83%55.13M10.25%53.68M26.93%64.83M11.59%209.44M6.98%52.94M17.50%56.74M6.02%48.69M
Selling and administrative expenses -17.24%47.92M9.64%197.56M-1.14%44.92M-2.31%48.08M12.57%46.66M31.34%57.9M11.67%180.18M6.87%45.43M18.86%49.22M5.20%41.45M
Depreciation amortization depletion -0.35%6.91M-3.85%28.12M-5.00%7.13M-6.24%7.05M-3.05%7.01M-0.89%6.93M11.10%29.25M7.66%7.51M9.31%7.52M10.97%7.24M
-Depreciation and amortization -0.35%6.91M-3.85%28.12M-5.00%7.13M-6.24%7.05M-3.05%7.01M-0.89%6.93M11.10%29.25M7.66%7.51M9.31%7.52M10.97%7.24M
Operating profit 24.65%141.5M19.71%534.94M22.25%153.27M26.31%141.81M20.15%126.34M9.08%113.52M32.67%446.87M43.58%125.38M32.23%112.27M34.13%105.15M
Net non-operating interest income expense -20.83%5.12M-48.87%12.78M-52.78%3.72M-79.85%1.52M-80.27%1.08M56.87%6.46M5,222.13%25M327.49%7.88M7,269.52%7.53M500.07%5.47M
Total other finance cost 20.83%-5.12M48.87%-12.78M52.78%-3.72M79.85%-1.52M80.27%-1.08M-56.87%-6.46M-5,222.13%-25M-327.49%-7.88M-7,269.52%-7.53M-500.07%-5.47M
Other net income (expense) 153.47%971K-231.61%-5.34M-125.44%-158K52.29%-489K-2,061.65%-2.88M-139.54%-1.82M719.24%4.06M-59.75%621K36.02%-1.03M89.63%-133K
Gain on sale of security -----1,458.67%-7.73M----------------74.29%-496K------------
Other non- operating income (expenses) 153.47%971K-47.43%2.39M577.98%7.57M52.29%-489K-2,061.65%-2.88M-139.54%-1.82M257.30%4.55M-67.83%1.12M36.02%-1.03M89.63%-133K
Income before tax 24.90%147.59M13.96%542.38M17.14%156.83M20.26%142.84M12.72%124.54M4.78%118.17M41.78%475.92M47.60%133.88M42.76%118.78M45.86%110.48M
Income tax 563.52%23.72M27.56%91.25M28.68%21.7M41.84%31.7M54.89%34.28M-64.92%3.58M35.30%71.54M35.90%16.86M76.67%22.35M50.80%22.13M
Net income 8.09%123.87M11.56%451.12M15.48%135.13M15.25%111.14M2.16%90.26M11.70%114.6M42.99%404.39M49.45%117.02M36.68%96.43M44.68%88.35M
Net income continuous Operations 8.09%123.87M11.56%451.12M15.48%135.13M15.25%111.14M2.16%90.26M11.70%114.6M42.99%404.39M49.45%117.02M36.68%96.43M44.68%88.35M
Minority interest income
Net income attributable to the parent company 8.09%123.87M11.56%451.12M15.48%135.13M15.25%111.14M2.16%90.26M11.70%114.6M42.99%404.39M49.45%117.02M36.68%96.43M44.68%88.35M
Preferred stock dividends
Other preferred stock dividends 00000-76.96%44K-94.34%3K00
Net income attributable to common stockholders 8.09%123.87M11.57%451.12M15.48%135.13M15.25%111.14M2.16%90.26M11.75%114.6M43.07%404.34M49.55%117.02M36.77%96.43M44.77%88.35M
Basic earnings per share 15.38%4.3519.75%15.6426.46%4.7827.01%3.9510.88%3.1613.55%3.7741.96%13.0648.24%3.7835.22%3.1142.50%2.85
Diluted earnings per share 16.62%4.2820.98%15.2827.25%4.6728.24%3.8612.73%3.114.69%3.6742.23%12.6349.19%3.6735.59%3.0142.49%2.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More